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ABSTRACT. We examined effects of topical application of leukotrienes (LT) C 4 , D4, and E 4 on cerebral arteries of newborn pigs in vivo. Diameters of pial arteries were measured using a cranial window method during application of artificial cerebrospinal fluid without drug, and cerebrospinal fluid containing LT C, D4, and L (1, ] 0, 100, 1000, and 5000 ng/ml). Control diameters ranged from 51-345 JLm. All three LT constricted pial arteries in a dosedependent manner, with a threshold for detectable response at 10 nglml (7 ± 3% for LTD4). The magnitude of constrictor response at the highest dose was 23 ± 3% for LTC4, 17 ± 2% for LTD 4 , and 17 ± 3% for LTE 4 . The specific receptor antagonist FPL 55712 blocked the constrictor response to LT. We conclude that LT are potent constrictors of cerebral arteries in newborn pigs. (Pediatr Res 20: 973- 976, 1986) LT are a group of biologically active compounds that are derived from arachidonic acid via the 5-lipoxygenase pathway (I, 2). The peptidoleukotrienes (LTC4, 0 4 , E4, and F4) are synthetized by various peripheral tissues in response to injury (1, 2) and have potent effects on vascular tone (3) (4) (5) (6) and permeability (7) (8) (9) . The LT also are synthesized by brain under a variety of pathological conditions (10, 11) , but knowledge of the effects of these substances on cerebral vessels is limited and the results are contradictory (12) (13) (14) (15) . Further, effects of LT on the newborn cerebral circulation have not been investigated. The risk of cerebral trauma during the perinatal period is considerable. LT have potent effects on the pulmonary and systemic circulations in neonatal animals (16) . The purpose of this study was to determine effects of LTC4, LT04, and LTE4 on pial arteries of newborn pigs. Pial arteries are important resistance vessels in the cerebral circulation (17) .
of either sex were used in these experiments. Piglets were anesthetized with ketamine hydrochloride (33 mg/kg, intramuscular) and acepromazine (3.3 mg/kg, intramuscular), and were maintained on a-chloralose (30-50 mg/kg initially, supplemented with 5 mg/kg/h, intravenous). Following a tracheostomy, a tube was placed into the airway and the animals were intubated and ventilated with room air using a Harvard small animal respirator. A catheter was inserted into a femoral artery to record blood pressure and to sample for blood gases and pH. Blood pressure was determined using a Statham pressure transducer, and the output was displayed on a Gould recorder. Another catheter was inserted into a femoral vein for injection of drugs and fluid. Body temperature was maintained at 37-38°C with water circulating heating pad.
For insertion of cranial window, the scalp was removed and an opening, approximately 2 cm in diameter, was made in the skull over the parietal cortex with bone rongeurs. The dura was cut and reflected over the cut bone edge. A cranial window, similar to that described by Levasseur et al. (18) was placed into the hole and cemented into place with dental acrylic. After the dental acrylic hardened, the space under the window was filled with artificial CSF. We used artificial CSF of the following composition: 220 mg KCI, 132 mg MgCb, 221 mg CaCh, 7710 mg NaCl, 402 mg urea, 665 mg dextrose, 2066 mg NaHC0 3 per liter; pH = 7.33; PCOz = 46 mm Hg; POz = 43 mm Hg.
Previously we have shown that this artificial CSF does not affect resting pial arterial diameter in piglets (19) .
Pial arteries were observed with a Wild M7S trinocular stereomicroscope, television camera (model VC-65SL, Oage-MIT, Michigan City, IN) mounted on the microscope, and video monitor (model CT-1930V, Panasonic Corporation Secaucus, NJ). We selected one artery exposed by the craniotomy in the range of 150-345 JLm and, in some cases, a smaller artery « 150 JLm) in the viewing field. We never studied more than two vessels per animal. Vascular diameter was measured with a video microscaler (model VPA-l000, For-A-Corp, Los Angeles, CA).
Protocol. Pial arterial diameter was determined 2-4 min following infusion under the window of artificial CSF containing no drug and after infusion of CSF containing 1, 10, 100, 1000, and 5000 ng/ml ofLTC4, (eight vessels from five animals), LT0 4 (11 vessels from six animals), and LTE 4 (eight vessels from four animals). We also measured diameter 10-15 min after flushing the leukotrienes out with CSF containing no drug. We typically flushed 1-2 ml ofCSF over 30 s through the window each time. Needles incorporated into the sides of the window allowed infusion of CSF under the window and run-off of excess CSF. One dose response curve to a single LT was performed per animal. We measured the peak response, which was constant over 2-4 min after administration of CSF containing leukotrienes. Subsamples of the synthetic leukotrienes were repeatedly subjected to high-pressure liquid chromatography to confirm that insignificant decomposition had occurred during storage (Fig. I) . Infusion of CSF without LT had no effect on diameter. 973 In order to determine whether constrictor responses to LT were prevented by LT receptor blockade, we determined effects ofLTC 4 (six vessels from three animals) and LTD4 (three vessels from two animals) at a dose of 5000 ng/ml before and after addition of FPL 55712 (1000-5000 ng/ml) to CSF. Following the application ofleukotriene to the cortical surface, we reapplied this dose ofLT with FPL 55712. No tachyphalaxis occurred over this time period. We also assessed effects of 10-4 M c10nidine HCI (Sigma, St. Louis, MO) and 10-4 M c10nidine plus FPL 55612 (1000 ng/ml) on pial arteries (three vessels from two pigs).
Pial arterial diameter and arterial pressure in the dose-response experiment were analyzed using repeated measures analysis of variance. If the F value was significant, the Student-NewmanKuels test was performed. The relationship between initial diameter and response to leukotrienes (all data from LTC 4 , LTD 4 , and LTE4 at 5000 ng/ml were pooled) was analyzed using linear regression analysis and the unpaired t test. Control diameter was compared with recovery diameter (after leukotrienes) using paired t tests. Effectiveness of receptor blockade was analyzed using a paired t test, comparing percent change from control in the absence ofFPL 55712 and in the presence of this antagonist. Control diameter was compared to 10-4 M c10nidine with and without FPL 55721 using paired t tests. a-Level of p < 0.05 was considered significant in all statistical tests. Values are presented as means ± SEM of raw values or as percent change from control values. .g)J was examined using an isocratic high-pressure liquid chromatography system. The system consisted ofa u-Bondapack CI8 column (3.9 mm x 30 cm; Waters Assoc., Milford, MA) using a buffer of 45% acetronitrile: 55% water (containing 0.1 % acetic acid; buffer pH adjusted to 5.7 with ammonium hydroxide). The solvent was delivered with a Waters liquid chromatography pump (model 6000A; Waters Assoc.). The leukotrienes were detected spectrophotometrically at 280 nm (AUFS -0.1) using an UV detector(modeI450, Waters Assoc.) and recorded on a chart recorder (Series 5000; Fisher Scientific, Lexington, MA) at a constant paper speed of5 mm/min. 
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RESULTS
Infusion of LT in CSF under the cranial window did not affect arterial blood pressure (Table I) .
LT C4, D4, and E4 had dose-dependent constrictor effects on pial arteries (Table 1 ; Fig. 2 ). At the lowest dose (1 ng/ml), LT did not reduce arterial diameter significantly. At 10 ng/ml, LTD 4 but not LTC4 and LTE4, constricted pial arteries. At the higher doses, all three LT constricted pial arteries (LTC 4 : 100 ng/ml < 1000 ng/ml = 5000 ng/ml) (LTD4: 10 ng/ml < 1000 ng/ml = 5000 ng/ml) (LTE4: 100 ng/ml = 1000 ng/ml < 5000 ng/ml).
Magnitude of responses to the three LT was not different statistically except at 1000 ng/ml, where LTC 4 > LTE 4 (Fig. 2) .
Recovery diameter was 156 ± 42 JLm for LTC (significantly different from initial control, see Table 1 ), 155 ± 24 tLID for LTD4 (nonsignificant compared to control), and 122 ± 27 tLID (nonsignificant compared to control).
Initial control diameter of the pial arteries examined had a modest bearing on the magnitude of the constrictor response to LT. Small « 150 tLm) pial arteries constricted to a slightly greater extent than large arteries (150-345 tLm) (22 ± 2%; n = 14 versus 15 ± 2%; n = 13, for small and large arteries, respectively). For pooled data for all three LT at 5000 ng/ml, the correlation coefficient (initial diameter/percent change in diameter) was 0.46 ability in skin (7) (8) (9) 21) . The effects of LT on the cerebral circulation have not been studied extensively, and the results are inconclusive. Von Holst et at. (15) found that LTC 4 and LTD 4 had no effect on human cerebral arteries in vitro. In contrast, Tagari et at. (14) reported that human cerebral arteries contracted in response to LTD4, but this response was not blocked by FPL 55712, implying that the response was not due to activation of the LT receptors. Tagari et at. (14) also found that LTD 4 constricted rat intracranial arteries. Rosenblum (13) found that LTB4, C4, and D4 constricted small (30-45 11m) pial arteries by 7-13% in mice. There was no evidence of tachyphylaxis, and constrictor responses to LTC4 were attenuated by FPL 55712. Recently, Kamitani et at. (12) found that LTC 4 and LTD 4 did not constrict small (32-82 11m) pial arteries of rabbits, while LTB4 constricted these vessels by~5%. In our experiments, we looked at responses of pial arteries over a large range of sizes (i.e. 51-345 11m initial diameter) and found that LTC., D 4 , and E 4 constricted these vessels from 17-23% at the highest doses. This response is relatively large, as we have found that arterial hypertension and exogenous norepinephrine (2 x 10-4 M) constrict piglet pial arteries by 10 and 15%, respectively (19) . On the basis ofPoiseuille's law, constriction of the magnitude induced by LT would have substantial effects on resistance. We also found that the threshold for detectable constriction was 10 ng/ml for LTD 4 • The present report is the first one to document that LTE 4 is a constrictor agent in the cerebral circulation. Potency was LTC 4 = LTD4 and LTC4 > LTE4• We also examined the relationship between initial diameter and response to LT. There was a modest tendency for small pial arteries « 150 11m) to constrict to a greater extent than large arteries (150-345 11m), but this difference was only about 7%. It should be emphasized that pial arteries of the sizes used in the present study are important resistance vessels in the cerebral circulation (17) . The reason for differences in findings is unclear, but may be due to different methods of administration of LT (intraarterial versus topical application), different doses, and species variation. Our results are consistent with preliminary findings of Piper and Stanton (22) , in which they report that LTC 4 and LTD 4 reduced intracranial blood flow in juvenile pigs.
It has been reported that LT can be synthesized in brain during pathological conditions such as cerebral ischemia, subarachnoid hemorrhage, and concussive brain injury, and levels of LT can reach as high as 12 ng/g of brain (10, 11) . We have found that LT begin to constrict cerebral arteries at doses as low as 10 ng/ ml CSF. The risk of cerebral trauma during the perinatal period is considerable. Infants can become hypoxic-ischemic at birth, and a large percentage of low birth weight (:s 1000 g) infants suffer from intraventricular hemorrhages. Under conditions of cerebrovascular stress in neonates, LT may be released, which would have possible detrimental effects on the cerebral circulation. Fig. 3 . Effects of leukotrienes (5000 ng/ml) alone or leukotrienes (5000 ng/ml) plus FPL 55712 (1000-5000 ng/ml) on pial arterial response to combined data for LTC4 (n = 6 vessels) and D4 (n = 3 vessels).
*p < 0.05, compared to control. tp < 0.05, compared to response after FPL 55712.
DISCUSSION
The present study demonstrates that the peptidoleukotrienes C 4 , D 4 , and E 4 have potent constrictor effects on pial arteries of newborn pigs. Each of these LT lead to a dose-dependent decrease in diameter, and responses were blocked by the specific antagonist FPL 55712. These results, indicating that the responses resulted from activation of LT receptors, provide direct evidence that pial arteries are responsive to products of 5-lipoxygenase in the immediate neonatal period.
LT have been shown to constrict resistance vessels in coronary (3, 5, 6) , pulmonary (16) , and mesenteric (4) circulations, although contradictory evidence has been reported (4, 20) . In addition, LT also have been reported to increase vascular permeThe specific receptor antagonist FPL 55712 was effective in blocking pial arterial constriction to leukotrienes (Fig. 3) . For these experiments, diameter was 189 ± 40 11m (arterial pressure = 63 ± 3 mm Hg) during control, 168 ± 38 11m (arterial pressure = 59 ± 5 mm Hg) in the presence ofLTC 4 or D 4 , and 186 ± 39 11m (arterial pressure = 58 ± 5 mm Hg) in the presence of LTC. or LTD4 plus FPL 55712. In three vessels from two other animals, diameter during control w~.s 173 ± 14 11m, was significantly reduced to 138 ± 15 11m during 10-4 M clonidine, and was still significantly reduced to 150 ± 16 11m during 10-4 M clonidine plus FPL 55712.
